Navidea Biopharmaceuticals Inc

OTC: NAVB    
Share price (5/2/24): $0.04    
Market cap (5/2/24): $3.503 million

Indentures Filter

EX-4.10
from S-3 17 pages Certificate of Designation of Preferences, Rights and Limitations of Series I Convertible Preferred Stock of Navidea Biopharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 3 pages First Amendment to Section 382 Rights Agreement
12/34/56
EX-4.21
from S-1/A 3 pages Navidea Biopharmaceuticals, Inc. Subscription Rights Offering
12/34/56
EX-4.20
from S-1/A 14 pages Warrant Agency Agreement
12/34/56
EX-4.19
from S-1/A 22 pages Navidea Biopharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.18
from S-1/A 18 pages Certificate of Designation of Preferences, Rights and Limitations of Series I Convertible Preferred Stock of Navidea Biopharmaceuticals, Inc
12/34/56
EX-4.21
from S-1/A 3 pages Navidea Biopharmaceuticals, Inc. Subscription Rights Offering
12/34/56
EX-4.20
from S-1/A 14 pages Warrant Agency Agreement
12/34/56
EX-4.19
from S-1/A 22 pages Navidea Biopharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.18
from S-1/A 18 pages Certificate of Designation of Preferences, Rights and Limitations of Series I Convertible Preferred Stock of Navidea Biopharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 62 pages Navidea Biopharamaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC, as Rights Agent Section 382 Rights Agreement Dated as of April 7, 2022
12/34/56
EX-4.6
from S-3 41 pages Navidea Biopharmaceuticals, Inc. Indenture Dated as of , 20 [Trustee], Trustee
12/34/56
EX-4.5
from S-3 15 pages Registration Rights Agreement
12/34/56
EX-4.3
from 10-K 3 pages Description of Securities
12/34/56
EX-4.3
from S-3 2 pages Indenture or similar
12/34/56
EX-4.1
from 8-K 20 pages Underwriter’s Common Stock Purchase Warrant Navidea Biopharmaceuticals, Inc
12/34/56
EX-4.9
from S-3 42 pages Navidea Biopharmaceuticals, Inc. Indenture Dated as of , 2017 [Trustee], Trustee
12/34/56
EX-4.1
from 8-K 24 pages Form of Warrant Navidia Biopharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 1 page Certificate of Elimination of Navidea Biopharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 11 pages Navidea Biopharmaceuticals, Inc. Amended and Restated Certificate of Designations, Voting Powers, Preferences, Limitations, Restrictions, and Relative Rights of Series B Convertible Preferred Stock
12/34/56